Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme

  • Anna Maria Di Giacomo, Luana Calabrò, Riccardo Danielli, Ester Fonsatti, Erica Bertocci, Isabella Pesce, Carolina Fazio, Ornella Cutaia, Diana Giannarelli, Clelia Miracco, Maurizio Biagioli, Maresa Altomonte, Michele Maio
  • Cancer Immunology Immunotherapy, April 2013, Springer Science + Business Media
  • DOI: 10.1007/s00262-013-1418-6

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1007/s00262-013-1418-6